New market leader for clinical cytogenetics laboratory services
Posted: 6 September 2010 | | No comments yet
Sure Laboratories is an independent clinical cytogenetics service laboratory providing dedicated microarray-based comparative genomic hybridisation screening…
Sure Laboratories is an independent clinical cytogenetics service laboratory providing dedicated microarray-based comparative genomic hybridisation screening...
Sure Laboratories is an independent clinical cytogenetics service laboratory providing dedicated microarray-based comparative genomic hybridisation (arrayCGH) screening for detection of copy number imbalance and aneuploidy. Established in early 2010 by BlueGnome – the specialist developer of microarray solutions for human cytogenetic investigations – the laboratory has rapidly established itself as the leading provider of clinical arrayCGH screening services, thanks to its combination of low cost, rapid turnaround of results and a team of highly trained specialist staff.
Independent fertility specialist CARE Fertility Group is already taking advantage of Sure Laboratories pre-implantation genetic screening (PGS) service using the breakthrough 24sure technology, as Managing Director Dr Simon Fishel explained: “We are very happy with the excellent customer service we receive from the dedicated team at Sure Laboratories. Their unmatched service quality, combined with the industry leading, proven 24sure technology, ensures rapid sample analysis, significantly enhancing implantation rates while minimising the risk of multiple pregnancies for our patients.”
Sure Laboratories has been designed from the ground up to provide a broad range of cytogenetic tests, with purpose-built facilities and state-of-the-art workflows to ensure rapid turnaround of results and the highest quality standards, for both UK and international clients. The Company uses BlueGnome’s advanced CytoChip technology and industry-standard BlueFuse Multi software, and offers a library of over 26,000 fluorescent in situ hybridisation (FISH) probes for crucial follow-up investigations.
“It is vital that microarray investigations are performed to the highest possible standards, and the rapid growth of Sure Laboratories supports our belief that this is best provided by a dedicated service organisation,” commented Nick Haan, co-founder of BlueGnome and acting CEO of Sure Laboratories.
For further information please about Sure Laboratories, visit www.surelaboratories.com
